Results 231 to 240 of about 3,085,481 (399)

Chromosome Complements in Grasses [PDF]

, 1926
G.A. Evans
openalex   +1 more source

Cerebral Amyloid Angiopathy Is Associated With Higher R2 Relaxation Rate: An MRI and Pathology Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cerebral amyloid angiopathy (CAA) involves β‐amyloid deposition in the walls of cortical and leptomeningeal small vessels. Transverse relaxation rate (R2) is a major source of contrast in MRI. This study tested the hypothesis that CAA is associated with R2, extracted the spatial pattern of CAA‐related R2 abnormalities, and evaluated ...
Md Tahmid Yasar, Arnold M. Evia, Mahir Tazwar, Sue E. Leurgans, David A. Bennett, Julie A. Schneider, Konstantinos Arfanakis   +6 more
wiley   +1 more source

Diagnosis of Epidemic Encephalitis by Complement-fixation Tests

, 1941
J. Casals
openalex   +2 more sources

Serum Complement, Rheumatoid Factor, and Other Serum Proteins in Rheumatoid Disease and Systemic Lupus Erythematosus [PDF]

, 1959
H. A. Ellis, D. Felix-Davies
openalex   +1 more source

Very High‐Frequency Oscillations in Mesial Temporal Lobe Epilepsy: Identifying the Epileptogenic Zone

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate the reliability of very high‐frequency oscillations (VHFOs, 500–2000 Hz) as biomarkers in identifying the epileptogenic zone (EZ) in mesial temporal lobe epilepsy (MTLE) patients. Methods We reviewed 19 MTLE patients who underwent stereo‐electroencephalography‐guided radiofrequency thermocoagulation.
Stéphane Jean, Yihai Dai, Yan Cui, Donghuo Deng, Zhe Qian, Panashe Tevin Tagu, Weitao Chen, Weihong Liu, Xiaoqiang Wei, Xinrong Fang, Shiwei Song   +10 more
wiley   +1 more source

Involvement of a Complement-Like Factor in the Activation of Blood Protease [PDF]

, 1952
Walton B. Geiger
openalex   +1 more source

Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration

Science, 2005
J. Haines, M. Hauser, S. Schmidt, W. Scott, L. Olson, P. Gallins, Kylee L. Spencer, S. Y. Kwan, M. Noureddine, J. Gilbert, N. Schnetz-Boutaud, A. Agarwal, E. Postel, M. Pericak-Vance   +13 more
semanticscholar   +1 more source

ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This phase 3b, open‐label, randomized ADAPT NXT study investigated the efficacy, safety, and tolerability of efgartigimod administered in either a fixed cycles dosing regimen (3 cycles of 4 once‐weekly infusions, with 4 weeks between cycles) or a cycle followed by every‐other‐week (Q2W) dosing.
Ali A. Habib, Kristl G. Claeys, Vera Bril, Yessar Hussain, Kelly Gwathmey, Gregory Sahagian, Elena Cortés‐Vicente, Edward Brauer, Deborah Gelinas, Anne Sumbul, Rosa H. Jimenez, Daniela Hristova, Delphine Masschaele, Renato Mantegazza, Andreas Meisel, Shahram Attarian, On behalf of the ADAPT NXT Study Group   +16 more
wiley   +1 more source

Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Kidney International Reports, 2022
Jolijn R. van Leeuwen, Obbo W. Bredewold, Laura S. van Dam, Stella L. Werkman, Jacqueline T. Jonker, Miranda Geelhoed, Antonius P.M. Langeveld, Hilde H.F. Remmelts, Maud M. van den Broecke, Argho Ray, Ton J. Rabelink, Y.K. Onno Teng   +11 more
doaj  

On the Action of Complement as Agglutinin [PDF]

, 1906
Robert Muir, C. H. Browning
openalex   +1 more source